Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study-Reference-Cited by-同舟云学术

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Published:2024-01 Issue: Volume: Page:
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Reilmann Ralf,Anderson Karen E,Feigin Andrew,Tabrizi Sarah J,Leavitt Blair R,Stout Julie C,Piccini Paola,Schubert Robin,Loupe Pippa,Wickenberg Anna,Borowsky Beth,Rynkowski Gail,Volkinshtein Rita,Li Thomas,Savola Juha-Matti,Hayden Michael,Gordon Mark Forrest,Guttman Mark,Raymond Lynn,Mendis Tilak,Suchowersky Oksana,Corey-Bloom Jody,Geschwind Michael D,Marshall Frederick J,Marder Karen S,Nance Martha,Racette Brad,Bang Jee,Segro Victoria,McDonell Katherine,Kamholz John,LeDoux Mark S,Sanchez-Ramos Juan,DeMichele Giuseppe,Mariotti Caterina,Squitieri Ferdinando,Soliveri Paola,Cortelli Pietro,Muñoz García José Esteban,Kulisevsky Bojarski Jaime,López-Sendón Moreno José Luis,Berganzo Corrales Koldo,Cubo Esther,García Moreno José Manuel,Orth Michael,Priller Josef,Saft Carsten,Weindl Adolf,Winkler Juergen,Craufurd David,Miedzybrodzka Zofia,Rickards Hugh,Davies Rhys Richard,Lahiri Nayana,Ruddy Deborah,Komati Suresh K,Quarrell Oliver William John,Correira Guedes Leonor,Roos Raymund A C,Zalyalova Zuleykha,Illarioshkin Sergey,Gustov Aleksandr,Klempir Jiri

Funder

Teva Pharmaceutical Industries Ltd

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference36 articles.

1. The role of the immune system in Huntington's disease;Ellrichmann;Clin Dev Immunol,2013

2. Positive effect of immunomodulatory therapies on disease progression in Huntington's disease? Data from a real-world cohort;Achenbach;Ther Adv Neurol Disord,2022

3. Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis;Varrin-Doyer;Exp Neurol,2014

4. Placebo-controlled trial of oral laquinimod for multiple sclerosis;Comi;N Engl J Med,2012

5. A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis;Vollmer;J Neurol,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laquinimod, Huntington's disease, and disease modification;The Lancet Neurology;2024-01